yahoo_financeOriginal article
Seres Therapeutics to Host Webcast on July 8, 2026, to Discuss Results of Investigator-Sponsored Trial of Seres’ SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis
Data ReadoutSER-155Neutral
AI Analysis
Summary
Seres Therapeutics will host a webcast on July 8, 2026, to discuss results from an investigator-sponsored trial of SER-155 in immune checkpoint inhibitor-related enterocolitis.
Clinical Trial Data
Outcome Details
Investigator-sponsored trial results to be discussed
Importance:5/10
Sentiment:
0.00
data readoutinvestigator-sponsored trialwebcastSER-155immunology
Related Companies
Read the original article
Published by yahoo_finance on June 25, 2026 11:00 AM